Quality‐of‐Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient‐Oriented Outcomes and External Experts

Documenti analoghi

• Quality of Life Measurement in Autoimmune Blistering Diseases: Mutual Position Statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Autoimmune Blistering Diseases
  di: Pavel V. Chernyshov, et al.
  Pubblicazione: (2025)
• Quality of life measurement in urticaria: Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient‐Oriented Outcomes and Urticaria and Angioedema
  di: P. V. Chernyshov, et al.
  Pubblicazione: (2024)
• Position Statement of the EADV Task Forces With External Experts on Quality of Life Measurement in Hidradenitis Suppurativa: An Update
  di: Pavel V. Chernyshov, et al.
  Pubblicazione: (2026)
• Quality of life measurement in assessing treatment effectiveness in urticaria: European experts position statement
  di: Pavel Viktorovich Chernyshov, et al.
  Pubblicazione: (2024)
• Reduction in Dressing Change Burden in Patients With Epidermolysis Bullosa—Impact of Oleogel‐ S10
  di: Anna L. Bruckner, et al.
  Pubblicazione: (2025)